Actively Recruiting

Phase 1
Age: 18Years +
All Genders
NCT07450911

A Clinical Study Evaluating the Replacement of the Native Mitral Valve Using the ReValve System

Led by ReValve Solutions Inc. · Updated on 2026-03-05

20

Participants Needed

3

Research Sites

100 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

An evaluation of the ReValve System for treatment of clinically significant mitral regurgitation in subjects determined appropriate for mitral valve surgery.

CONDITIONS

Official Title

A Clinical Study Evaluating the Replacement of the Native Mitral Valve Using the ReValve System

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Symptomatic mitral regurgitation of grade 3 or higher due to ischemic or non-ischemic cardiomyopathy confirmed by recent echocardiograms
  • New York Heart Association (NYHA) Functional Class II, III, or ambulatory IV
  • Left ventricular ejection fraction (LVEF) of 30% or greater based on imaging in the past 90 days
  • Age over 18 years
  • Left ventricular end systolic dimension (LVESD) of 65 mm or less based on recent echocardiogram
Not Eligible

You will not qualify if you...

  • Untreated clinically significant coronary artery disease needing revascularization
  • Need for urgent or emergency surgery or planned cardiac surgery within 12 months
  • Status 1 heart transplant or prior orthotopic heart transplantation
  • Stroke (cerebrovascular accident) within 30 days before consent
  • Pregnant or planning pregnancy within the next 12 months
  • Participation in another investigational drug or device study
  • Evidence of left ventricular or left atrium thrombus, vegetation, or mass
  • Known allergy or contraindication to procedural or post-procedural medications, including contrast solution, anticoagulation therapy, nickel, or titanium

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 3 locations

1

Healthycore

Tbilisi, Georgia

Actively Recruiting

2

Tbilisi Heart and Vascular Center

Tbilisi, Georgia

Actively Recruiting

3

Tiblisi Heart Center

Tbilisi, Georgia

Actively Recruiting

Loading map...

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

A Clinical Study Evaluating the Replacement of the Native Mitral Valve Using the ReValve System | DecenTrialz